TNF and inflammatory bowel disease: Selectively sequestering IL‐23 has proven successful in reducing inflammation associated with psoriasis (Hawkes et al. 2018) and offers an alternative to the widely prescribed anti‐tumour necrosis factor (TNF) sequestering therapies commonly used in the treatment of IBD (Gaffen et al. 2014).